Maria Bozika

Dr. Maria Bozika

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
MBMaria Bozika
Maria Bozika
Anastasios ApostolosAnastasios Apostolos
Anastasios Apostolos
Kassiani-Maria NastouliKassiani-Maria Nastouli
Kassiani-Maria Nastouli
Michail PapafaklisMichail Papafaklis
Michail Papafaklis
ISIoannis Skalidis
Ioannis Skalidis
Grigorios TsigkasGrigorios Tsigkas
Grigorios Tsigkas
A revolutionary non-invasive method for the thorough evaluation of coronary artery disease (CAD) is fractional flow reserve (FFR) obtained from coronary computed tomography angiography (CCTA). Computed tomography-derived FFR (FFRCT) assesses both the anatomical and functional significance of coronary lesions simultaneously by utilizing sophisticated computational models, including computational fluid dynamics, machine learning (ML), and Artificial Intelligence (AI) methods. The technological development, validation research, clinical uses, and real-world constraints of FFRCT are compiled in this review. Large multicenter trials and registries consistently show that FFRCT is a reliable gatekeeper to invasive coronary angiography (ICA) and increases diagnostic accuracy significantly when compared to coronary Computed Tomography Angiography (CTA) alone, especially in patients with intermediate-risk anatomy. Additionally, FFRCT has demonstrated benefits in populations with in-stent restenosis (ISR) and in virtual procedural planning. Notwithstanding its advantages, the technique still requires high-quality imaging, and its practical application is constrained by expenses, processing requirements, and image distortions. Continuous developments in automation and deep learning should improve accessibility, effectiveness, and workflow integration in clinical settings. FFRCT is expected to become more and more important in the individualized treatment of CAD by minimizing unnecessary invasive procedures and improving patient selection for revascularization.

27 April 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Georgios LeventopoulosGeorgios Leventopoulos
Georgios Leventopoulos
Kassiani-Maria NastouliKassiani-Maria Nastouli
Kassiani-Maria Nastouli
MBMaria Bozika
Maria Bozika
HPHELEN PAPASTAVROU
HELEN PAPASTAVROU
Anastasios ApostolosAnastasios Apostolos
Anastasios Apostolos
PDPeriklis Davlouros
Periklis Davlouros
Cardiac resynchronization therapy (CRT) using biventricular (BiV) pacing is the standard treatment for heart failure (HF) patients with reduced left ventricular ejection fraction (LVEF) and electrical dyssynchrony. However, one in three patients remains a non-responder. Left bundle branch area pacing (LBBAP) could represent a more physiological alternative, but its effectiveness is limited in cases of atypical left bundle branch block (LBBB) or intraventricular conduction delay (IVCD). Left Bundle Branch Pacing Optimized cardiac resynchronization therapy (LOT-CRT) integrates LBBAP with coronary sinus (CS) lead pacing to improve electrical synchrony and clinical outcomes. This review evaluates the feasibility, advantages, disadvantages, and clinical outcomes of LOT-CRT. Additionally, we describe our center’s experience and propose an evidence-based implantation algorithm. A review of published studies investigating LOT-CRT was conducted, comparing its effectiveness with BiV-CRT and LBBAP alone using QRS narrowing, LVEF improvement, left ventricular remodeling, New York Heart Association (NYHA) class changes and NT-proBNP levels. It was found that LOT-CRT outperforms BiV-CRT or LBBAP alone in selected populations, at the cost of higher clinical skills, longer procedural times, and specific device setups. Randomized trials are underway to further define its role in clinical practice.

Verified
Journal Article
Open access
PDF file
Grigorios TsigkasGrigorios Tsigkas
Grigorios Tsigkas
Kassiani-Maria NastouliKassiani-Maria Nastouli
Kassiani-Maria Nastouli
Anastasios ApostolosAnastasios Apostolos
Anastasios Apostolos
PSPanagiota Spyropoulou
Panagiota Spyropoulou
MBMaria Bozika
Maria Bozika
PDPeriklis Davlouros
Periklis Davlouros
Percutaneous Coronary Intervention (PCI) has advanced significantly with the incorporation of imaging and physiology assessment techniques. Fractional Flow Reserve (FFR) and Non-Hyperemic Pressure indices (NHPIs) provide information regarding the functional significance of coronary lesions, while Intravascular Ultrasound (IVUS) and Optical Coherence Tomography (OCT) enhance anatomical characterization and guide stent implantation. This review explores the implementation of physiology- and imaging-guided strategies in clinical practice, comparing their efficacy and limitations. Novel technologies now allow for physiology estimation without hyperemic agents, and hybrid techniques, such as OCT-derived FFR, are increasingly integrated into clinical practice. These approaches offer the combined advantages of functional assessment and detailed anatomical imaging.

6 November 2025 in Hellenic Journal of Cardiology
Verified
Journal Article
Open access
Grigorios TsigkasGrigorios Tsigkas
Grigorios Tsigkas
MBMaria Bozika
Maria Bozika
Michail PapafaklisMichail Papafaklis
Michail Papafaklis
ISIoannis Skalidis
Ioannis Skalidis
Kassiani-Maria NastouliKassiani-Maria Nastouli
Kassiani-Maria Nastouli
PDPeriklis Davlouros
Periklis Davlouros
Wire-free fractional flow reserve (FFR) methods derived from coronary angiography offer a less invasive alternative to pressure-wire physiology assessment of intermediate coronary stenoses. During the last decade, several methodological approaches have shown strong correlation and high diagnostic accuracy compared to FFR values. However, clinical outcome studies are limited and widespread use of the wire-FFR computational methods is still lacking in routine patient management. In this review, we summarize the main technical characteristics of the available methodologies and focus on the clinical applications presenting the diagnostic performance according to various patient and anatomic subsets.

7 February 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
IKIoanna C. Koniari
Ioanna C. Koniari
MBMaria Bozika
Maria Bozika
Kassiani-Maria NastouliKassiani-Maria Nastouli
Kassiani-Maria Nastouli
DTDimitra Tzegka
Dimitra Tzegka
Anastasios ApostolosAnastasios Apostolos
Anastasios Apostolos
PDPeriklis Davlouros
Periklis Davlouros
Atrial fibrillation (AF) is the most common sustained arrhythmia, contributing to significant morbidity and healthcare burden worldwide. This review evaluates the role of early risk factor modification and timely catheter ablation in preventing AF progression and improving patient outcomes. A comprehensive literature search was conducted using PubMed, MEDLINE, and Google Scholar, focusing on studies published after the ESC 2020 guidelines for the diagnosis and management of AF up to the release of the updated ESC 2024 guidelines for the management of AF. Keywords included “atrial fibrillation”, “catheter ablation”, “risk factor management”, and “psychological stress”. Relevant clinical trials, randomized controlled trials, systematic reviews, and meta-analyses were included, with particular emphasis on novel studies contributing to the ESC 2024 updated recommendations. Traditional risk factors such as obesity, hypertension, diabetes, sleep apnea, alcohol consumption, and physical exertion are well established in AF progression. Early evidence also suggests a role for psychological stress and mood disorders, including depression and post-traumatic stress disorder (PTSD), in increasing AF susceptibility. Psychological stress and mood disorders are linked to AF primarily through behavioral changes such as poor medication adherence, unhealthy lifestyle choices, and increased substance use. Recent guidelines recommend early catheter ablation in selected patients to reduce AF burden, prevent atrial remodeling, and improve quality of life, particularly in those resistant to antiarrhythmic drugs or individuals with AF-induced cardiomyopathy. Furthermore, we highlight the importance of a patient-centered, multidisciplinary approach, integrating electrophysiologists, cardiologists, and primary care providers with structured risk factor interventions and shared decision-making. Despite these advances, gaps remain in defining optimal timing, patient selection, and long-term benefits of catheter ablation in persistent AF, necessitating the need for further research. By integrating early intervention, personalized treatment strategies, and collaborative care models, we may usher in a paradigm shift in AF management, improving long-term cardiovascular outcomes and patient quality of life.

Verified
Journal Article
Open access
PDF file
Nicholas KounisNicholas Kounis
Nicholas Kounis
Cesare de GregorioCesare de Gregorio
Cesare de Gregorio
Ming-Yow HungMing-Yow Hung
Ming-Yow Hung
GGGrigorios Giamouzis
Grigorios Giamouzis
ΜΜΜαρινα Μιχαλάκη
Μαρινα Μιχαλάκη
IKIoanna C. Koniari
Ioanna C. Koniari
Mast cell degranulation and other interacting and linked cells, including T-lymphocytes, macrophages, eosinophils, and platelets, as well as a range of inflammatory mediators produced during an anaphylactic or allergic reaction, constitute the main causes of Kounis syndrome. Acute ischemia episodes, coronary spasm, atheromatous plaque erosion/rupture, and platelet activation can all be caused by histamine, tryptase, arachidonic acid derivatives, and chymase in the Kounis syndrome cascade. Kounis syndrome can be triggered by a variety of factors, including medications, hymenopteran stings, metals, foods, environmental exposures, illnesses, and immunizations. In addition, some unusual, rare, intriguing, and significant causes of Kounis syndrome have been discovered recently, namely the “kiss of death”, where human kissing and pet kissing can induce fatal Kounis syndrome. Moreover, the clinical conundrum is that several of the main drugs and substances used to treat myocardial infarction and Kounis syndrome, such as adrenaline (epinephrine), aspirin, atropine, clopidogrel, corticosteroids, heparins, protamine sulfate, and hirudotherapy can also initiate it. Therefore, physicians should be aware of this clinical discrepancy to prevent catastrophic consequences.